Zim Laboratories Ltd, established in 1984 in Maharashtra, India, is a publicly traded company specializing in the manufacturing of drug formulations and pre-formulation ingredients. The company operates both domestically and internationally in a pharmaceutical market heavily influenced by multinational corporations and large Indian companies. Zim Laboratories expanded its operations by acquiring ZIM Health Technologies Limited in 2019-20, making it a wholly-owned subsidiary, and establishing SIA ZIM Laboratories Limited in Latvia.
In 2023, Zim Laboratories introduced Thinoral, a patented Oral Thin Film technology, which serves as an alternative drug delivery platform. This innovation targets the Rest of World (RoW), Pharmerging Markets, and the European Union, showcasing the company's focus on advanced drug delivery solutions and expansion into global markets.
